Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Timothy Kasunic (NPI 1013975903)

Field	Value
Entity Type	Individual
Organization	Timothy Kasunic
Address	1325 Conference Dr Ste 2010
City	Toledo
State	OH
ZIP	43614
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 2, 2006

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider is effectively single-payer in public programs: lifetime Medicare revenue is $2M while there is no Medicaid billing on file, so all reported public payor activity is concentrated in Medicare and there is no Medicaid footprint to assess. Analysts should treat this entity as Medicare-focused when modeling payor mix or contracting exposure.

Revenue concentration is high within a small set of oncology biologics: the precomputed top 3 Medicare codes by revenue account for 59.0% of this provider's total Medicare revenue, led by J9144 ($478.8K, 24.6%), J9271 ($448.4K, 23.1%), and J9299 ($220.3K, 11.3%). This concentration indicates most Medicare dollars flow from a few high-cost infusion agents rather than a broad mix of ancillary services.

The code mix and descriptions indicate an infusion-centered hematology/oncology practice. High-revenue oncology biologics (J9144 daratumumab, J9271 pembrolizumab, J9299 nivolumab) are the primary drivers, supported by chemotherapy administration codes such as 96413 (484 claims, $45.5K revenue) and G0498 (55 claims, $6.7K revenue), which together point to regular in-office infusion treatment delivery rather than a predominantly procedural or inpatient practice.

Competitive standing on the top drugs is modest rather than dominant: J9144 ranks #112 of 615 providers nationally (81th percentile; typical, unremarkable volume), J9271 ranks #967 of 1841 providers nationally (47th percentile; typical, unremarkable volume), and J9299 ranks #364 of 505 providers nationally (28th percentile; typical, unremarkable volume). These rank/percentile placements suggest the provider participates at typical volumes for these agents nationally and is not an outlier market leader.

There are programmatic signals of very high-frequency, low-dollar billing in specific items: J1439 shows 72.8K claims at $1 avg paid/claim for $72.8K revenue and ranks #129 of 1209 providers nationally (89th percentile; typical, unremarkable volume), and 96372 has 564 claims, $10 avg paid/claim, $5.6K revenue and ranks #1305 of 58224 providers nationally (98th percentile; notably above typical national volume). Together these suggest routine use of frequent, low-paid injectable treatments or supply-billed items alongside the high-cost biologics.

Clinical support and adjunct therapies also contribute meaningful Medicare revenue: J1569 immune globulin accounts for $178.3K (9.2%) and J9312 rituximab accounts for $140.3K (7.2%) of Medicare revenue, while J0897 denosumab contributes $141.5K (7.3%). These lines indicate the practice manages a spectrum of hematology/oncology care beyond immune checkpoint inhibitors, including immunoglobulin therapy and monoclonal antibody treatments.

Office evaluation-and-management revenue is present but secondary to infusion services: 99214 generated $49K (538 claims, 2.5% of Medicare revenue) and 99213 generated $13.9K (239 claims, 0.7%), with 99214 ranking #43311 of 479517 providers nationally (91th percentile; typical, unremarkable volume). This suggests that while the provider conducts E/M visits, the bulk of clinical activity and revenue derives from drug administration rather than face-to-face office visit billing.

This provider shows long-tenure enrollment in Medicare, with NPI enumerated 2006-05-02 (~20 years ago), which supports longitudinal experience in the oncology/hematology service line and may be relevant when considering referral patterns, historical utilization, or contracting relationships in the Toledo, OH market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

50 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	13,680	$40	$478.8K
J9271	Injection, pembrolizumab, 1 mg	11,800	$40	$448.4K
J9299	Injection, nivolumab, 1 mg	9,580	$20	$220.3K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	4,950	$40	$178.3K
J0897	Injection, denosumab, 1 mg	7,860	$20	$141.5K
J9312	Injection, rituximab, 10 mg	2,300	$60	$140.3K
J1439	Injection, ferric carboxymaltose, 1 mg	72,750	$1	$72.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	540	$90	$49K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	480	$90	$45.5K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	5,030	$10	$30.2K

Showing 1–10 of 50

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 50 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Timothy Kasunic — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

50 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	23	40	12,100	$40	$603K
J9144	1	10	10,260	$40	$380.5K
J9299	5	10	13,660	$20	$376.8K
J1569	8	20	4,900	$40	$203.8K
J9312	3	10	2,300	$60	$166.7K
J0897	31	230	2,880	$20	$79.5K
J2506	8	10	480	$80	$49.8K
J1439	4	20	20,250	$1	$27.4K
J9217	82	100	120	$130	$22.3K
96413	13	210	130	$90	$16.8K

Showing 1–10 of 50

Related Providers

Other providers that share a Tax Identification Number (TIN) with Timothy Kasunic, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Toledo Hospital	OH	General Acute Care Hospital	$0	$151.2M
University Of Toledo Physicians LLC	OH	Internal Medicine Physician	$0	$17.8M
Toledo Clinic Incorporated	OH	Surgery Physician	$0	$15.9M
Toledo Clinic Incorporated	OH	Clinical Medical Laboratory	$2.1M	$2M
Toledo Clinic Incorporated	OH	Clinic/Center	$2.4M	$812.9K
David Kouba	OH	Dermatology Physician	$1.9M	$0
Niraj Shah	OH	Ophthalmology Physician	$1.3M	$0
Shaili Desai	OH	Hematology & Oncology Physician	$1.2M	$0
Richard Phinney	OH	Medical Oncology Physician	$1.2M	$0
Mohammed Abusamieh	OH	Rheumatology Physician	$1.1M	$0

Nearby Providers

Other providers in the same ZIP code as Timothy Kasunic, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Medical University Of Ohio At Toledo	OH	General Acute Care Hospital	$0	$50.7M
Mohammad Rashid	OH	Hematology & Oncology Physician	$565.7K	$0
Satheesh Ramineni	OH	Adult Reconstructive Orthopaedic Surgery Physician	$314.9K	$0
Ellis Sampram	OH	General Practice Physician	$269.9K	$0
Raja Hanif	OH	Family Medicine Physician	$220.6K	$0
Charu Trivedi	OH	Hematology & Oncology Physician	$218.1K	$0
Mohammad Abdulrasool	OH	Family Medicine Physician	$179.7K	$0
Kunal Yadav	OH	Transplant Surgery Physician	$172.2K	$0
Daniel Gehling	OH	Adult Reconstructive Orthopaedic Surgery Physician	$166.5K	$0
Mark Buehler	OH	Diagnostic Radiology Physician	$164.7K	$0

Timothy Kasunic — Billing Profile & Reimbursement Data

Sign up for Timothy Kasunic — Billing Profile & Reimbursement Data policy alerts

Timothy Kasunic — Billing Profile & Reimbursement Data

Sign up for Timothy Kasunic — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References